NEVVI Medicare utilization intelligence

← back

Provider profile

GLASPY, JOHN MD

Hematology-Oncology · NPI 1639104250 · LOS ANGELES, CA

1
Groups
33
Codes · 2024
22,049
Disclosed services

GLASPY, JOHN is a Hematology-Oncology in LOS ANGELES, CA, a member of 1 medical group, who billed 33 distinct codes to Medicare Part B in 2024.

Groups: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (LOS ANGELES, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider analytics (2024)

GLASPY, JOHN billed 21,655 disclosed services in CY2023 and 22,049 in CY2024.

This provider's disclosed Medicare payments across all codes were $premium in CY2024.

The full figure is part of the market analytics platform — built, not launched yet. Notify me at launch →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg premiumpremium premiumpremium
J1453 Injection, fosaprepitant, 1 mg premiumpremium premiumpremium
J0897 Injection, denosumab, 1 mg premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
J2469 Injection, palonosetron hcl, 25 mcg premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count premiumpremium premiumpremium
J3480 Injection, potassium chloride, per 2 meq premiumpremium premiumpremium
J2405 Injection, ondansetron hydrochloride, per 1 mg premiumpremium premiumpremium
J7050 Infusion, normal saline solution, 250 cc premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour premiumpremium premiumpremium
96361 Infusion into a vein for hydration, each additional hour premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
36415 Insertion of needle into vein for collection of blood sample premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more premiumpremium premiumpremium
96415 Administration of chemotherapy into vein, each additional hour premiumpremium premiumpremium
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) premiumpremium premiumpremium
J7030 Infusion, normal saline solution , 1000 cc premiumpremium premiumpremium
96417 Administration of additional new drug or substance into vein, 1 hour or less premiumpremium premiumpremium
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes premiumpremium premiumpremium
J1200 Injection, diphenhydramine hcl, up to 50 mg premiumpremium premiumpremium
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes premiumpremium premiumpremium
96360 Infusion into a vein for hydration, 31-60 minutes premiumpremium premiumpremium
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more premiumpremium premiumpremium
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more premiumpremium premiumpremium
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.